Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder (NCT06847399)
Efficacy and Safety of Tirzepatide Versus Placebo or Lisdexamfetamine Dimesylate for Binge-Eating Disorder: A Randomized Clinical Trial
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to assess the efficacy and safety of tirzepatide in adults with obesity and binge-eating disorder, comparing tirzepatide against placebo and lisdexamfetamine dimesylate. All participants will receive guided self-help cognitive behavioral therapy.
Who can join: Review the eligibility criteria below.
Location: Johns Hopkins University — Baltimore, Maryland
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (1 Sites)
- Johns Hopkins University — Baltimore, Maryland
📞 Contact the Study Coordinator
Phone: (667) 306-9366
Email: abisson2@jh.edu
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Obesity and Overweight
- Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity — Scottsdale, Arizona
- Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese — Los Angeles, California
- Impact of Chia Seeds on Human Breast Milk Composition — Boston, Massachusetts
- Brain and Behavior Influences on Obesity Development From Infancy Through Childhood — Baltimore, Maryland
- FAMily-centered WEight Loss for Black Adults (FAM WEL B-ing) — Chapel Hill, North Carolina
- Metabotyping of Broccoli Microgreen in Obese Breast Cancer Survivors — Baltimore, Maryland
Explore by condition: All Obesity and Overweight clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.